The US FDA has approved Revolution Medicines’ daraxonrasib for adults [...]

Sagimet Biosciences is preparing to begin screening patients for its [...]

Polaryx Therapeutics is preparing to start its Phase 2 SOTERIA [...]

The FDA has granted De Novo marketing authorisation to Avulux, [...]

Limbic has been selected for the US Food and Drug [...]

AC Immune has received FDA Fast Track designation and IND [...]

The FDA has issued a Complete Response Letter for ITM-11, [...]

Adneuris Therapeutics has granted Maruishi Pharmaceutical exclusive rights to develop [...]

BlueWind Medical has received FDA 510(k) clearance for Revi Extend, [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]